Fibromyalgia is not a rheumatologic disease anymore

MedGenMed Medscape General Medicine

Volumn 10, Issue 2, 2008, Pages

  Griffing, George T ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DULOXETINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREGABALIN;

BRAIN FUNCTION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DRUG APPROVAL; DRUG EFFICACY; DRUG TREATMENT FAILURE; EDITORIAL; FIBROMYALGIA; HUMAN; MEDICAL SPECIALIST; MUSCULOSKELETAL PAIN; NEUROLOGIC DISEASE; PAIN THRESHOLD; PATIENT REFERRAL; RHEUMATIC DISEASE; SCORING SYSTEM; SPINAL CORD FUNCTION; CLASSIFICATION; NOMENCLATURE; UNITED STATES;

FIBROMYALGIA; HUMANS; RHEUMATIC DISEASES; TERMINOLOGY AS TOPIC; UNITED STATES;

EID: 41949133918     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. Graham W. The fibrositis syndrome. Bull Rheum Dis. 1953;3:33-34.
2. Wolfe F, Symthe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160-172.
3. Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med. 2007;146:726-734.
4. Clauw DJ. Fibromyalgia: update on mechanisms and management. J Clin Rheumatol. 2007;13:102-109.
5. Rooks DS. Fibromyalgia treatment update. Curr Opin Rheumat. 2007;19:111-117.
6. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264-1273.